Scott A Teitelbaum
Florida Recovery Center
Scott Teitelbaum, M.D. is the Pottash professor in psychiatry and neuroscience at the University of Florida College of Medicine, where he serves as vice chair of the department of psychiatry, chief of the division of addiction medicine, medical director of the UF Health Florida Recovery Center and former fellowship director of UF’s American Board of Preventative Medicine (ABPM) – addiction medicine fellowship.
He was originally trained and board-certified as a pediatrician. He always loved children and as a father, he thought it was important to treat a patient’s family the way he would want to be treated. He later completed fellowships in addiction medicine and child psychiatry at the University of Florida, switching focus because of his own journey in recovery and desire to help individuals who suffer with the effects of substance use disorders and co-occurring mental health conditions and their families. He became medical director of the Florida Recovery Center in 2002 and since then has been involved in the evaluation and/or treatment of more than 5,000 healthcare providers and other professionals from across the country. Through these efforts, the Florida Recovery Center has led the way nationally with its evidence-based treatment of the disease of addiction.
He developed one of the first-ever accredited fellowships in addiction medicine and the program has now trained more addiction medicine fellows than any other program nationwide. They are continuing research on substance biomarkers and using patient health assessments to identify where they can improve the quality of the treatment that they provide individuals.
In 2016, he was awarded the Pottash Endowment, allowing for the creation of a research initiative that’s focused on addiction medicine and the fight toward recovery. He has been honored on multiple occasions with the Exemplary Teacher Award for his guidance of medical students. He has also received multiple awards and honors, including being named the winner of the American Society of Addiction Medicine’s Prestigious Annual Award in January 2018 in recognition of his outstanding contributions to the field and elected into the Conway Hunter Society.
A national expert who has been consulted by the White House Office of National Drug Control and the U.S. Drug Enforcement Administration, he is passionate about reducing stigma and advancing treatment for those suffering from the disease of addiction. In his free time, he enjoys spending time with family, being outdoors, and exercising.